Many fungal species are able to reversibly switch from unicellular yeast to multicellular filamentous growth forms to adapt to and survive in adverse environmental conditions. Virulence is often tightly associated with filamentous growth. Candida albicans, one of the most frequently isolated opportunistic fungal pathogens of humans, can switch from yeast growth to pseudohyphal growth or hyphal growth. This ability is linked to pathogenicity (28) . In C. albicans, hyphal growth is characterized by robust polarized growth, active cell division at the tip cells of extending hyphae, and attachment of cells at septa, after cell division. This facilitates the penetration of C. albicans through epithelial or endothelial cells and the escape from macrophages (28, 37) . Diploid Saccharomyces cerevisiae, under conditions of nutrient limitation, forms chains of elongated yeast cells (pseudohyphae) where the daughters remain attached to the mothers (16) . Pseudohyphal growth is suggested to provide a means for immobile yeast cells to grow away from the initial ancestral cell and forage for nutrients. Despite some morphological differences between pseudohyphae and hyphae, cell chain formation remains an underlying common characteristic for filamentous growth among yeasts and other dimorphic fungi.
In S. cerevisiae, cell separation is achieved by degradation of the septum between mother and daughter cells at the end of each cell division. The transcription factor Ace2 controls the expression of several daughter-specific genes, such as CTS1 (chitinase) and SCW11. The enzymes encoded by Ace2 target genes degrade the septum from the daughter side during G 1 , resulting in cell separation (11, 39) . Ace2 localizes specifically to the daughter nucleus in late M and G 1 phases of the cell cycle. This daughter-specific nuclear localization requires the Cbk1 kinase and other components of the RAM (for regulation of Ace2 and morphogenesis) pathway and is negatively regulated by Cdc28 (3, 35, 39) . Deletion of any component of the RAM pathway, ACE2, or downstream enzymes results in impaired cell separation (23, 24, 35) . Cell separation in C. albicans is likely regulated by a similar mechanism. Ace2 localizes to the daughter nucleus during the late M and early G 1 phases of the cell cycle in C. albicans, and controls the transcription of a set of genes homologous to those activated by Ace2 in S. cerevisiae, such as CHT3 (CTS1 homolog) and SCW11 (22, 34) . Furthermore, deletion of ACE2, CHT3, or CBK1 all result in the impairment of cell separation in C. albicans (13, 22, 33) . Interestingly, during hyphal growth, CHT3 has been shown to be downregulated (32) . The mechanism and significance of the hypha-associated downregulation of CHT3 transcription remains unclear.
The transcription factor Efg1 plays an essential role in the regulation of the hyphal transcriptional program (28, 44) . Efg1 belongs to the APSES family of transcription factors that are important regulators of fungal development. This family includes the pseudohyphal regulators Phd1 and Sok2 of S. cerevisiae, StuA of Aspergillus nidulans, and Asm1 from Neurospora crassa, all sharing the conserved "APSES" DNA-binding domain (2) . Efg1 is required for the induction of hypha-specific genes (28, 44) and is suggested to function downstream of the cyclic AMP (cAMP)/protein kinase A (PKA) pathway (5) . Transcription profiling of cAMP signaling in C. albicans shows that many Efg1-regulated genes are distinct from those modulated by the adenylate cyclase Cyr1/Cdc35, except for the class of genes induced during the yeast to hypha transition (18) , suggesting that Efg1 is also regulated by factors in addition to the cAMP/PKA pathway.
Most hypha-specific genes encode cell wall proteins or secreted proteases. HGC1 is an exception. As a homolog of Cln1/Cln2 of S. cerevisiae, Hgc1 is a cyclin of Cdc28 in C. albicans and plays important regulatory roles in hyphal development (54) . Deletion of HGC1 results in impaired polarization and a defect in cell chain formation during hyphal growth. Since HGC1 is expressed specifically in hyphae (54) and its expression is restricted to the actively dividing apical cell (52) , it can act as a hypha-specific regulator. Phosphorylation of Rga2, a Cdc42 GAP, by Cdc28-Hgc1 has been shown to prevent Rga2 from localizing to hyphal tips, allowing Cdc42 activation and sustained polarized growth at the hyphal tips (55) . The mechanism for how Hgc1 regulates cell chain formation is not clear. Cdc28-Hgc1 has been shown to play a role in regulating the dynamics of septin rings during hyphal growth through Sep7 (17) . This change in the dynamics of septin rings results in reduced Cdc14 targeting to the mother-bud neck in hyphae (17) . Loss of Cdc14 at the neck is proposed to decrease RAM signaling leading to reduced Ace2 accumulation in the daughter nucleus (10, 17) . However, this has not been demonstrated.
Eukaryotic cells normally differentiate from G 1 cells. For hyphal development in C. albicans, cell chain formation is due to a persistent septum between postdivision mother and daughter cells. Degradation of this septum during yeast growth is accomplished by enzymes encoded by Ace2 activated genes, which are expressed in the G 1 phase of daughter cells. In the present study, we show that Efg1 is a negative regulator of Ace2 target genes involved in cell separation and that phosphorylation of Efg1 by Cdc28-Hgc1 downregulates these genes during hyphal growth in G 1 . Importantly, this regulation is essential for proper cell chain formation during hyphal growth. The daughter-specific nuclear localization of Ace2 in G 1 is not regulated by Efg1 or Cdc28-Hgc1 or during the yeast-to-hypha transition. In addition, Efg1 association with the promoters of Ace2 target genes is enriched in hyphae. The convergent regulation of genes involved in cell separation by Ace2 and Efg1 provides a mechanism for how the temporal regulation of these genes by Ace2 is integrated with a developmental signal through Efg1/Cdc28-Hgc1 to control cell chain formation in fungi.
MATERIALS AND METHODS

Plasmid construction. (i) pACT1-EFG1-MYC.
A 580-bp fragment containing 13xMYC was PCR amplified from the S. cerevisiae vector pFA6a-13MYC-HISMX6 (29) (with the oligonucleotides 5Ј-GCGGATCCATTTGCGGCCGCT TTACGACGCGTTCCCGGGTTAATTAACGGTGAA and 5Ј-ATCGCATGC GTGATTGATTAATTTTTGTTCACC) and cloned into the C. albicans pFlag-ACT1-URA3 vector (50) . NotI and MluI sites were introduced between BamHI and the 13MYC sequence. EFG1 was amplified from C. albicans genomic DNA (SC5314) (with 5Ј-CGGGATCCCATGTCAACGTATTCTATACCCTATTAC and 5Ј-GGCGACGCGTCGCTTTTCTTCTTTGGCAACAGTGCT). The resulting 1.65-kb PCR product was digested with BamHI and MluI and inserted into the BamHI MluI site to create pACT1-EFG1-MYC.
(ii) pEFG1-EFG1-MYC. A 3-kb EFG1 promoter fragment upstream of the START site of EFG (from Ϫ1 to Ϫ3000) was PCR amplified (with 5Ј-GAAG GCCTGCTGAGTATTTCTTCTTCTACAG and 5Ј-GAAGATCTTCGTCGAC TAATATGGGTTATATTCTTGG). The resulting purified PCR product was digested with StuI and BglII and cloned into the StuI-BamHI site of pACT1-EFG1-MYC, displacing the 1-kb ACT1 promoter region.
(iii) pACT1-EFG1
T179A
-MYC. Two-step PCR amplification was used to generate EFG1
. Two pairs of primers (the primers 5Ј-CGGGATCCCATGTC AACGTATTCTATACCCTATTAC and 5Ј-CTGAACAGGAGCTGGTTGTT GCATAGTACTTACATGTGGTGGGATAGGTACTGC and the primers 5Ј-C CACATGTAAGTACTATGCAACAACCAGCTCCTGTTCAGGATACGTT GAACGCC and 5Ј-GGCGACGCGTCGCTTTTCTTCTTTGGCAACAGT GCT) were used to PCR amplify overlapping EFG1 fragments with the mutation in the overlapping region, as well as an SphI site. The resulting PCR products were purified and mixed as templates for another round of PCR amplification (using the primers 5Ј-CGGGATCCCATGTCAACGTATTCTATACCCTA TTAC and 5Ј-GGCGACGCGTCGCTTTTCTTCTTTGGCAACAGTGCT), which produced the full-length EFG1 T179A sequence. The resulting mutant, EFG1
, was cloned into the BamHI-MluI site of the plasmid pACT1-EFG1-MYC, replacing the wild-type copy, and was confirmed by DNA sequencing and SphI digestion.
(iv) pEFG1-EFG1
T179D
-MYC. Two-step PCR was used to create EFG1
. Two pairs of primers (i.e., the primers 5Ј-CGGGATCCCATGTCAACGTATTCT ATACCCTATTAC and 5Ј-CTGAACAGGATCTGGTTGTTGCATAGTACTTA CATGTGGTGGGATAGGTACTGC and the primers 5Ј-CCACATGTAAG TACTATGCAACAACCAGATCCTGTTCAGGATACGTTGAACGCC and 5Ј-GGCGACGCGTCGCTTTTCTTCTTTGGCAACAGTGCT) were used to PCR amplify overlapping EFG1 fragments with the mutation in the overlapping region. Subsequent steps were done by using the same methods as pACT1-EFG1 T179A -MYC, except that the ACT1 promoter was later replaced with the EFG1 promoter in the same manner as pEFG1-EFG1-MYC.
(v) pMAL2-EFG1-HBH. The HBH tag was PCR amplified from pFA6a-HBH-kanMX6 (45) with MluI and PacI restriction enzyme sites and a stop codon at its C terminus (using the primers 5Ј-CGACGCGTAACAGGGGT TCACATCATCACC and 5Ј-CCTTAATTAAGAAGTCGCGCGCCTCATT AATGATGG). This was inserted into MAL2p-MYC-HGC1 (52). MYC-HGC1 was then replaced with PCR-amplified EFG1 from genomic DNA (SC5314) flanked by XbaI and MluI sites (using the primers 5Ј-GCTCTAG AATCGATATGTCAACGTATTCTATACC and 5Ј-CGACGCGTGCATGC CAATGACTGAACTTGGGATG).
(vi) pHGC1-TAP-Hgc1. The TAP tag was PCR amplified with BamHI and MluI sites (using the primers 5Ј-GGAAGATCTCCATGAAAGGTGATGCGC AAAATAAC and 5Ј-CGACGCGTCGCGCCATAATCAAGTGCCCC) and cloned into HGC1p-MYC-HGC1 (52), replacing the 13xMYC tag.
(vii) pACE2-MYC. A 1-kb C-terminal fragment of the ACE2 coding region was PCR amplified with BamHI and MluI sites using the primers 5Ј-GGCGACGC GTCGTTGCAACATTAAAAACTCCTCA and 5Ј-CGGGATCCCAGAATTT AGGTGCCATGGG and cloned into pPR673 (30) .
C. albicans strain construction. Strains and genotypes are listed in Table 1 . Wild-type strains containing C-terminal Myc-tagged Efg1 and Efg1
(HLY3499 and HLY3747, respectively) were created by transforming 4-fluoorotic acid-treated efg1 cells (HLC52) with BamHI-digested pEFG1-EFG1-MYC or pEFG1-EFG1
-MYC. BamHI cuts at a unique site within the EFG1 promoter region, resulting in EFG1-MYC integrated into the endogenous EFG1 locus. The wild-type strain (HLY3499) is fully functional, since it can undergo proper morphogenesis and activate hypha-specific genes (data not shown). In addition, no difference between SC5314 and HLY3499 was observed in the temporal expression of CHT3 and other cell cycle-regulated genes. BamHIdigested pEFG1-EFG1T179D-MYC was transformed into hgc1 cells (HLY3435) to create an hgc1 EFG1/EFG1 T179D strain (HLY3853). efg1 T179A (HLY3485) was created by PCR amplifying a 3.2-kb (EFG1-13MYC-URA3-3ЈEFG-UTR) product from pACT1-EFG1
T179A
-MYC using primers that span from the START site of EFG1 (5Ј-CGGGATCCCATGTCA ACGTATTCTATACCCTATTAC) and a primer that flanked the 3Ј-untranslated region (3ЈUTR) region of EFG1 and also consisted of complementary sequences to the N-terminal region of the URA3 gene (5Ј-CGTTCATGTCAA TGGATTTGGGAGAAGATTATGATCTATACTATTTCTTTTTTTATTATT TGATTGTAATAGTAATAATTACC). This PCR product was integrated at the EFG1 locus by transformation into 4-fluoorotic acid-treated efg1 (HLC52) to create HLY3485.
Efg1-HBH (HLY3748) was created by transforming BWP17 with an SphIdigested pMAL2-EFG1-HBH. SphI cuts at a unique site within EFG1, resulting in EFG1-HBH integrated into the endogenous EFG1 locus.
TAP-Hgc1 (HLY3749) was created by transforming BWP17 with an AscIdigested pHGC1-TAP-HGC1. This resulted in TAP-HGC1 under the regulation of its own promoter integrated into the ADE2 locus.
TAP-Hgc1-Cdc28as (HLY3827) was created by replacing the URA3 in a Cdc28as strain (a gift from P. Sudbery) with a PCR-amplified nourseothricin resistance cassette (NAT) (40) , flanked with complementary sequences to URA3 in the primers. The resulting Ura Ϫ Cdc28as strain was then transformed with AscI-digested pHGC1-TAP-HGC1, resulting in TAP-HGC1 under the regulation of its own promoter integrated into the ADE2 locus.
ACE2-GFP efg1 (HLY3750) and ACE2-GFP hgc1 (HLY3751) strains were generated by transforming efg1 (HLC52) or hgc1 (HLY3435) strains with an ACE2-green fluorescent protein (GFP) PCR product (with the primers 5Ј-GAAT TGGACAATTACTGGAC and 5Ј-TCGAGTAACAATTCGACTGGT) from genomic DNA of the ACE2-GFP strain (MK127).
ACE2-MYC (HLY3825) and ACE2-MYC efg1 (HLY3826) strains were made by transforming BWP17 and efg1 (HLC52) strains with PmlI-digested pACE2-MYC. PmlI cuts once in the ACE2 coding region of pACE2-MYC, resulting in integration of ACE2-GFP into the ACE2 locus.
Elutriation. C. albicans G 1 cells were collected by using centrifugal elutriation as described previously (19) from late-log-phase cells grown in yeast extract peptone plus 2% raffinose or, in the case of Fig. 2B (SC5314 and efg1 [HLC52] ), 2% dextrose medium at 30°C. For hyphal inductions, cells were monitored via microscopy during the time course to ensure Ͼ90% hyphal induction.
Northern analysis. Methods for RNA isolation and Northern blot hybridization were carried out as previously described (25) . Probes for HGC1, CCN1, and ACT1 were made as previously described (52) . Probes for CHT3, SCW11, DSE1, and PGA38 were made by PCR amplification of ϳ400-bp fragments from coding regions of each gene from SC5314 genomic DNA. The primers used were as follows: CHT3, 5Ј-TCCCGATGCTTCTGTTGGTC and 5Ј-CGAAGTTGGTG CTGTGGAGGT; SCW11, 5Ј-TCCAAGTCCAAGCTCAAGTACAGG and 5Ј-GGAGAAGGCACATTTACTCCCAAA; DSE1, 5Ј-CAAACATATTAGCCGC AGGACA and 5Ј-TGGTGGTGGTAGTGGAGGTA; and PGA38, 5Ј-CTGTT GCACCGAACTTGTCA and 5Ј-CAGTTTCTTGTGGAGTACCAGA.
In vitro kinase assay. Substrate was purified from strain (HLY3748) containing a C-terminal HBH-tagged Efg1. Efg1-HBH was purified by using a two-step purification with Ni-Sepharose 6 FastFlow resin (GE) and monomeric avidin beads (Pierce). HLY3748 was grown in SCϪUra medium plus 100 mM biotin to an optical density of 0.8. Cells were broken by using a FastPrep machine (MP) in binding buffer (20 mM sodium phosphate, 0.3 M NaCl, 20 mM imidazole, 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 g of leupeptin/ml, 1 g of aprotinin/ml [pH 7.4]) in denaturing conditions (8 M urea) . After binding to NiSepharose resin, Efg1-HBH was renatured by washing with binding buffer containing decreasing concentrations of urea. Efg1-HBH was eluted with elution buffer (20 mM sodium phosphate, 0.3 M NaCl, 250 mM imidazole, 1 mM PMSF, 1 g of leupeptin/ml, 1 g of aprotinin/ml [pH 7.0]). Eluates were incubated with monomeric avidin beads for 2 h and then washed five times with 10 bead volumes of phosphate-buffered saline.
Kinase was purified from a strain (HLY3749) containing an N-terminal TAPtagged HGC1 under the control of its own promoter. Cells were induced for hyphae in yeast extract-peptone-dextrose (YPD) plus serum at 37°C for 1 h for the expression of TAP-Hgc1. TAP-Hgc1 was purified from cell lysates by using calmodulin beads (Strategene) in buffer A (50 mM Tris, 150 mM NaCl, 10 mM EDTA, 10% glycerol, 1 mM PMSF, 1 g of leupeptin/ml, 1 g of aprotinin/ml, 1% NP-40, 1 mM sodium orthovanadate [pH 8]). TAP-Hgc1 was eluted with kinase buffer minus MgCl 2 plus 5 mM EGTA. MgCl 2 was added to the elution to chelate EGTA before the kinase assay. The wild-type strain SC5314 was used for an untagged HGC1 control for this assay. Kinase assays were performed on either 5 or 10 l of avidin beads with bound Efg1-HBH. Purified TAP-Hgc1 and Efg1-HBH-bound avidin beads were incubated in kinase buffer plus 1 l of [␥- 32 P]ATP at room temperature for 30 min. In the case of Cdc28as/TAP-Hgc1, purified kinase was incubated for 10 min with 1NM-PP1 at a final concentration of 25 M or an appropriate dilution of dimethyl sulfoxide as a vehicle control before the addition of [␥-32 P]ATP. Beads with bound phosphorylated Efg1-HBH were then washed twice with PBS. Phosphorylated Efg1-HBH was eluted by boiling in sodium dodecyl sulfate loading buffer plus 2 mM biotin. Phosphorylated Efg1-HBH was then separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The gels were dried and exposed to a phosphorimager screen.
Microscopy. Images were obtained on either a Zeiss Axioplan 2 or an inverted Zeiss Axio Observer.Z1 microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY) fluorescent system equipped with the AttoArc HBO 100 and the X-Cite series 120 mercury lamps, respectively. Images were taken using a ϫ100 NA 1.4 objective lens. Both fluorescence microscopes were equipped with GFP and DAPI (4Ј,6Ј-diamidino-2-phenylindole) filter sets. Processing was done using the software packages Axiovision 3.1 and 4.6.3, as well as Photoshop (Adobe Systems, Inc., Mountain View, CA).
ChIP. Chromatin immunoprecipitation (ChIP) analysis was performed as previously described (9) . A 2-g portion of anti-Myc antibody (Santa Cruz) was incubated with the cell extract from 50 ml of cells. ChIP experiments were quantitated using iQ SYBR green Supermix (Bio-Rad) on an iCycler iQ detection system (Bio-Rad). ChIP results were quantitated against a standard curve of serial diluted C. albicans genomic DNA. The PCR primers used in the ChIP analysis were as follows: CHT3, 5Ј-CATCTTGCAGAATTTAACGG and 5Ј-GTTATGCTTATTGCCCATAC; SCW11, 5Ј-CATTGCAAAATTTCAACG GTAAA and 5Ј-AATCAAAGTTTGCAAATCCTCGTA-3Ј; DSE1, 5ЈAAGA GATCACCCCCTACAGACTAT and 5Ј-TGGTTGTTAATTAAATTTTGT GGA; and ADE2, 5Ј-TGATGGTAGAGGTA and 5Ј-TTTGGCTAATATAG ATGCCT.
RESULTS
CHT3 is expressed during the M/G 1 phases of the yeast cell cycle and repressed in the G 1 phase in hyphae. To assess whether Ace2 target genes are expressed during a specific phase of the cell cycle like their S. cerevisiae homologues, we first examined CHT3 expression in synchronous cultures of hyphal cells. The CHT3 transcript was not detected in the initial G 1 phase during germ tube formation but began to appear at around 140 min and declined at 180 min (Fig. 1A) . The Northern was probed with CCN1 (for C. albicans cyclin), and chitin ring formation was monitored for the timing of the G 1 /S transition (19) . In addition, early anaphase cells were counted based on the unique elongated DAPI staining that correlates to cells with long mitotic spindles (19) . The peak of CHT3 transcript was at 160 min, i.e., 10 min after the peak of mitotic cells and before the G 1 /S transition. This timing led us to conclude that CHT3 is expressed in late M/early G 1 phases of the cell cycle in hyphal cultures. The same temporal pattern of CHT3 expression was observed in a strain containing Cterminal Myc-tagged Efg1 as the sole source of Efg1 (Fig. 1B) . The timing of CCN1 expression was used as a cell cycle marker for comparison to Fig. 1A .
To investigate whether previously reported downregulation of CHT3 in hyphae involves any temporal regulation, we examined CHT3 expression in synchronous cultures of yeast cells for comparison to the hyphal experiments. CHT3 transcript was hardly detectable during the initial G 1 phase and began to rise during late M phase of the first cell cycle, as observed in hyphal cells. However, unlike what was observed in hyphal cells, CHT3 transcript level extended throughout the subsequent G 1 phase (Fig. 1C) . The pattern of temporal expression of CHT3 during cell cycle progression was similar to that of its homologue CTS1 in S. cerevisiae (12) . The timing of CCN1 expression remained consistent between yeast and hyphae, suggesting hypha-specific repression of CHT3 during G 1 phase rather than a change of cell cycle timing.
The peak levels of CHT3 expression between yeast and hyphal cells were similar. When RNA fractions with the highest levels of CHT3 from the synchronous yeast and hyphal experiments (Fig. 1B and C) were analyzed on the same Northern blot, they showed similar levels of CHT3 expression (Fig. 1E, right panel) . Therefore, the previously reported hypha-specific downregulation of CHT3 in asynchronous cultures (32) is due to its temporal repression in G 1 phase during hyphal development.
Hypha-specific repression of CHT3 expression requires Hgc1. Because HGC1 is specifically expressed in hyphae and the hgc1 deletion displays a defect in cell chain formation during hyphal growth, Cdc28-Hgc1 is a possible regulator of the hypha-specific repression of CHT3 during G 1 . Therefore, we examined CHT3 expression during cell cycle progression in synchronous cultures of hyphal cells in an hgc1 deletion (Fig.  1D) . The hgc1 deletion exhibited an initial peak of CHT3 transcript during germ tube formation at the first G 1 , which was not seen in wild-type cells during yeast or hyphal growth. (Fig.  1E) . The peak in the initial G 1 was only seen in hgc1 mutants (Fig. 1E, left panel) , and the peak fractions in the subsequent late M phase were similar to wild-type yeast and hyphae (Fig.  1E , right panel), suggesting temporal differences rather than a general increase in CHT3 transcript throughout hyphal development in hgc1 mutants. Efg1 is a negative regulator of Ace2 target genes involved in cell separation. Genome-wide transcription analysis of Efg1 regulated genes revealed that CHT3 and SCW11 were upregulated in efg1 mutants and downregulated during EFG1 overexpression (our unpublished data). We confirmed this by Northern analyses, shown in Fig. 2A and B. High levels of CHT3 and SCW11 transcripts were observed in the efg1 mutant in both yeast and hyphal growth conditions in comparison to the wild-type strain, suggesting that Efg1 is required for repression of these genes ( Fig. 2A) . As expected for wild-type cells, the levels of CHT3 and SCW11 were lower in hyphae than in yeast. In Fig. 2B, CHT3 and SCW11 transcript levels were decreased when EFG1 was overexpressed compared to a wild-type strain grown in the same growth medium, further establishing Efg1 as a negative regulator of Ace2 target genes.
We investigated the effects of efg1 mutants on levels of CHT3 expression during the cell cycle in synchronous yeast cultures versus a wild-type strain (SC5314) (Fig. 2C) . In the efg1 mutant, CHT3 transcript levels were very high in the initial G 1 phase and were cyclical, presumably being detected in late M phase and the subsequent G 1 phase. Therefore, despite the high CHT3 expression in the efg1 mutant in the initial G 1 , CHT3 still retained a cell cycle-associated pattern of expression. We also observed that the efg1 cells entered the cell cycle much earlier than the wild-type cells, but the timing between the CCN1 peaks remained similar between the efg1 strain and wild-type control. Our Northern data suggest that Efg1 exerts its effects on CHT3 expression during the G 1 phase of the cell cycle when Ace2 is active.
Efg1 is phosphorylated by Cdc28-Hgc1 in vitro. To determine whether Efg1 is a substrate of the Cdc28-Hgc1, we performed an in vitro kinase assay using affinity purified TAPHgc1-Cdc28 from hyphal cells and Efg1-HBH, affinity purified in a denaturing condition from yeast cells. Phosphorylation of Efg1-HBH by Cdc28-Hgc1 was observed in the in vitro kinase assay but not detected in the untagged control (Fig. 2D) . To ensure the specificity of the kinase assay, we repeated it with affinity-purified TAP-Hgc1 from a strain with an analog-sensitive Cdc28 (Cdc28as) as the sole Cdc28. Efg1 was phosphorylated by TAP-Hgc1-Cdc28as in the absence of inhibitor 1NM-PP1, not in the presence of the inhibitor. Therefore, Efg1 is phosphorylated by Hgc1-bound Cdc28 in vitro. The in vitro phosphorylation of Efg1 by Cdc28-Hgc1, combined with the fact that Efg1 is required for repression of Ace2 target genes, suggests that Efg1 is a potential target of Cdc28-Hgc1 that regulates the genes involved in cell separation.
A strain containing a threonine-to-alanine mutation at position 179 in Efg1 mimics the hgc1 deletion in temporal expression of Ace2 target genes and displays impaired cell chain formation during hyphal growth. Efg1 has six potential minimal cyclin-dependent kinase (CDK) sites (S/TP) at T179, S381, T423, T507, S520, and S534. The site at position T179 is the only one conserved among Efg1 homologues (Fig. 2E) , and it is located near the conserved DNA-binding domain (residues 203 to 306). To investigate whether phosphorylation of Efg1 at T179 has any effect on the expression of Ace2 target genes, we engineered a T-to-A mutation on Efg1 to prevent phosphory- lation at T179. An EFG1 T179A -MYC fusion was integrated into its endogenous locus under the EFG1 promoter in an efg1 deletion strain to create a strain with the EFG1 T179A -MYC as its sole source of Efg1 (efg1 T179A ). efg1 T179A was not defective in the induction of hypha-specific genes during hyphal growth (data not shown) and displayed a similar level of Efg1 T179A -myc to that of Efg1-myc (Fig. 3D) . To determine the effect of the T-to-A mutation on CHT3 expression, we examined CHT3 transcript levels during cell cycle progression with synchronous cultures of efg1 T179A cells under hyphal growth conditions. The pattern of CHT3 expression in efg1 T179A cells (Fig. 3A) was strikingly similar to what we observed in the hgc1 mutant (Fig.  1D) . The CHT3 expression was observed during the initial G 1 and then in M throughout the subsequent G 1 phase as if cells were in yeast form. Because efg1 T179A cells expressed HGC1 at levels similar to the wild type (Fig. 3C) , the phenotype of efg1 T179A cells on CHT3 expression could not be caused by lack of HGC1. Our data suggest that phosphorylation of Efg1 at T179 is essential for Cdc28-Hgc1-mediated repression of CHT3.
To address whether other Ace2 target genes are also regulated by Hgc1 and Efg1 during hyphal growth, we examined the expression levels of CHT3, SCW11, DSE1, and PGA38 during initial hyphal induction in wild-type, efg1, efg1 T179A , and hgc1 strains (Fig. 3B) . Transcripts of all of these genes were barely detected in wild-type hyphal cells. In the efg1 mutant, transcript levels were very high as expected, further solidifying Efg1 as a repressor of Ace2 target genes involved in cell separation. efg1 T179A and hgc1 cells behaved similarly, with the levels of these transcripts higher than in wild-type hyphal cells and yet lower than in the efg1 mutant cells. Therefore, efg1
T179A behaves similarly to hgc1 in the regulation of CHT3 and other Ace2 target genes.
If repression of these genes during hyphal growth is important for proper cell chain formation, efg1 T179A cells should also have a defect in cell chain formation like hgc1 cells. Indeed, when synchronous hyphal cells that had undergone more than one cell division were examined for hyphal chain formation, separation of apical hyphal cells from mother cells were evident in both hgc1 and efg1 T179A strains (Fig. 3E) . The control wild-type cells formed long hyphae with strong septal junctions between mother and daughter cells. hgc1 cells, as reported (54) , were impaired for polarized growth and displayed a large population of separated mother and daughter cells. In synchronous cultures of efg1 T179A cells, elongated but separated cells began to accumulate after the cells had entered the second cell cycle (about 240 min). Therefore, efg1 T179A cells were impaired in hyphal chain formation but did not display a severe defect in polarized growth, a finding consistent with a normal level of HGC1 expression. The phenotypes observed in the efg1 T179A mutant provide a direct link between the hypha-specific downregulation of Ace2 target genes and cell chain formation during hyphal growth in addition to demonstrating that phosphorylation of Efg1 at T179 is essential for this regulation.
Strains containing the phosphomimic T-to-D mutation at position 179 in Efg1 display enhanced cell chain formation. To further examine the effects of phosphorylation on Efg1 at T179, we engineered a phosphomimic T-to-D mutation in EFG1. An EFG T179D -MYC fusion was integrated into the endogenous EFG1 locus in an efg1 deletion strain, resulting in a strain EFG1 T179D that carries the T-to-D mutation as its sole source of Efg1. Efg1 T179D -myc was detected at a level similar to Efg1-myc (Fig.  4B) , and the EFG1 T179D mutant had no detectable defect in hyphal development (data not shown). If phosphorylation of T179 during hyphal growth by Cdc28-Hgc1 is a signal for Efg1 to repress Ace2 target genes and this repression is important for cell chain formation, then EFG1 T179D should repress Ace2 target genes and show enhanced cell chain formation during yeast growth when HGC1 is not expressed. We examined this possibility with wild-type and EFG1 T179D cells grown for 5 h in YPD at 30°C for yeast growth. Expression levels of CHT3 and SCW11 in EFG1 T179D cells were much lower than that of the wild-type strain in yeast form (Fig. 4A) . The reduced levels of Ace2 targets correlated with an obvious increase in cell chain formation in the EFG1 T179D strain (Fig. 4C) . The chains of yeast cells observed with EFG1 T179D cells were not due to cells being flocculent but reflected a defect in cell separation as cells were held together by septa (Fig. 4C, as indicated by arrows) . In comparison, ace2 mutants showed more robust and constitutive cell chain formation than the EFG1 T179D mutant (data not shown). The phenotypes of the EFG1 T179D mutant suggest that phosphorylation at T179 on Efg1 is sufficient to trigger downregulation of Ace2 target genes and cell chain formation. If so, the EFG1 T179D mutant is predicted to suppress the cell separation defect of hgc1 cells during hyphal growth. To test this, we generated a double mutant of hgc1 EFG1 T179D . The EFG T179D -MYC construct with 3-kb upstream sequence was integrated into the endogenous EFG1 promoter in an hgc1 deletion strain, leaving both copies of wild-type EFG1 intact. To assess phenotypes, hgc1 and hgc1 EFG1/EFG1 T179D cells were grown for 4 h in YPD plus 10% serum at 37°C for hyphal growth and examined by differential interference contrast (DIC) microscopy. By 4 h, hgc1 cells were separated, and very few chains of two or more cells were seen (Fig. 4D ). In contrast, hgc1 EFG1/EFG1 T179D cells displayed an obvious increase in cell chains containing three or more cells (Fig. 4D) . This phenotype suggests that EFG1 T179D is epistatic to hgc1 for cell separation during hyphal growth.
Ace2 nuclear localization and protein levels are not affected during hyphal development. In S. cerevisiae, Ace2 activity and the expression of Ace2 target genes correlate directly to Ace2 localization to the daughter nucleus in G 1 (20, 36) . In C. albicans, it has been proposed that reduced expression of Ace2 target genes during hyphal growth is regulated at the level of Ace2 localization (17) . To determine whether Hgc1/Efg1 represses Ace2 target gene expression by altering the Ace2 level and/or nuclear localization, we examined Ace2-GFP localization in wild-type, hgc1, and efg1 strains. Because only a very small percentage of cells in asynchronous cultures gave detectable Ace2-GFP, we observed Ace2-GFP localization in synchronous cultures at 10-min intervals as cells proceeded into mitosis and subsequent G 1 phases. In the wild type, a small population of cells with Ace2-GFP localized to both the mother and daughter nucleus was observed in large budded cells after nuclear division (Fig. 5A) . In subsequent time points, this population was replaced with a considerably greater number of cells displaying daughter-specific nuclear localization of Ace2-GFP (Fig. 5A) . Both yeast and hyphal cells showed a similar pattern of Ace2-GFP nuclear localization ( Fig. 5A and B) . In addition, time-lapse microscopy revealed similar timing of Ace2 localization between yeast and hyphal cells (data not shown). Because there was no significant difference in Ace2-GFP localization, the downregulation of Ace2 target genes during hyphal growth is most likely not regulated at the level of Ace2 protein localization. Consistent with this, Ace2-GFP localization in hgc1 during hyphal growth was the same as in wild-type cells (Fig. 5B) . Ace2-GFP localization in efg1 mutants, where we observed the largest upregulation of Ace2 target genes, also behaved similarly to that in wild-type cells (Fig. 5A) . The Ace2-GFP signal intensity was similar in all of the strains tested, suggesting that this regulation does not occur by altering the Ace2 protein level. This was further confirmed by a Western analysis of Ace2 protein levels in yeast and hyphal growth conditions, as well as in efg1 cells (Fig. 6C) . Together, our data suggest that the Hgc1/Efg1-mediated repression of Ace2 target genes during hyphal growth is not regulated by altering the Ace2 protein level or localization.
Efg1 is detected at the promoters of Ace2 target genes. To determine whether Efg1 acts directly on the promoters of Ace2 target genes, we performed ChIP (Fig. 6A) . Efg1-myc expressed in wild-type cells was detected upstream of CHT3 preferentially in hyphal cells and yielded higher signal than Ace2-myc at the same promoter (Fig. 6B) . Furthermore, Efg1-myc displayed a decrease in association in hgc1 hyphal cultures compared to the wild-type hyphae. Consistent with its phenotype, Efg T179D -myc in yeast phase displayed increased association with the CHT3 promoter versus the wild-type (Fig. 6A) . Therefore, Hgc1 phosphorylation at T179 may enhance Efg1 binding to the CHT3 promoter. We then examined whether Efg1 binding to the promoter is dependent on Ace2. ChIP of Efg1-myc in an ace2 deletion strain showed that Efg1 bound more strongly to the promoter of CHT3 than that in wild-type cells (Fig. 6A) . Thus, Efg1 displays increased occupancy at the CHT3 promoter region in the absence of the activator Ace2. We also examined other Ace2 target gene promoters. Although we detected much weaker signal, the upstream region of SCW11 and DSE1 followed a similar trend with CHT3. Our ChIP data suggest that Efg1 is at the promoters of Ace2 target genes in hyphae and that phosphorylation at T179 of Efg1 affects its association with the promoters.
Because Efg1 displays increased association in hyphal cultures and in the ace2 deletion, one possible mechanism is that Efg1 and Ace2 binding to the promoters is competitive or mutually exclusive. Efg1 could be preventing the binding of Ace2 and vice versa. To test this, we did ChIP experiments with a C-terminal Myc-tagged Ace2 in yeast and hyphal cultures, as well as in the efg1 deletion in yeast growth conditions. There was no significant difference in Ace2 association with the promoter in any of these conditions.
DISCUSSION
Cell chain formation is a common feature for all filamentous growth in fungi. In this report, we show that phosphorylation of Efg1 by hypha-specific Cdc28-Hgc1 controls cell chain formation by repressing the expression of Ace2 target genes. Both the hgc1 deletion and the cells carrying a T-to-A mutation of Efg1 at T179 display a similar loss of hypha-specific repression on the transcription of Ace2 target genes, suggesting that the phosphorylation at T179 on Efg1 is essential for this transcriptional repression. Importantly, the hypha-specific repression is required for cell chain formation during hyphal growth, as efg1 T179A and hgc1 strains display defects in cell chain formation. The phosphorylation at T179 is sufficient to impose the hypha-specific repression of the Ace2 target genes, as a strain containing the phosphomimic T-to-D mutation at this site (EFG1 T179D ) results in a downregulation of these genes and the formation of cell chains even in yeast form where HGC1 is not expressed. Furthermore, cells with the phosphomimic mutation can suppress cell separation defects in an hgc1 strain during hyphal growth. We suggest that phosphorylation at T179 of Efg1 serves as a signal for hypha-specific repression of Ace2 target genes , which is essential for cell chain formation during hyphal development. This provides a first molecular link between a developmental signal and the transcriptional control for cell separation or chain formation in fungi. It also provides one of a few demonstrated examples for signal-induced repression in developmental signaling (1) .
In addition to Hgc1, other developmental or growth signals may also regulate the Ace2 target genes through Efg1. Ace2 target genes are not expressed during the initial G 1 phase in both yeast and hyphal growth conditions, whereas they are strongly expressed during the initial G 1 phase in the efg1 deletion strain. This suggests that Efg1 is responsible for the repression of Ace2 target gene expression in the initial G 1 phase in both yeast and hyphal growth. Along the same line, both the efg1 T179A mutant and the hgc1 deletion only display a partial loss of the repression of these genes during the initial G 1 in hyphal growth. A likely explanation is that Efg1 can transmit other signals besides Hgc1 to regulate the repression of Ace2 target genes. The cAMP/PKA pathway is a good candidate since Efg1 is suggested to act downstream of the cAMP/PKA pathway (5) . Further examination of genome-wide expression data for the cAMP/PKA pathway (18) reveals that the CHT3 level is increased in cyr1/cdc35 and ras1 mutants. We propose that Efg1 is a developmental regulator of Ace2 target genes involved in cell separation that integrates different growth and developmental signals such as cAMP/PKA and Cdc28-Hgc1. This model is attractive as C. albicans undergoes many different developmental transitions (e.g., pseudohyphal formation or biofilm development) for which regulation of Ace2 target genes is important. For example, the expression of Ace2 target genes is essential for biofilm adherence (22) , and yet repression of Ace2 target genes is important for the layer of biofilm characterized by hyphal growth (4). Efg1 is also an important developmental regulator of the white to opaque switch and is differentially expressed in white phase (42, 43) . Interestingly, the level of the Ace2 target gene SCW11 in opaque cells is ϳ73-fold higher than that in white cells (47) .
hgc1 and efg1 T179A strains display a peak of CHT3 during the initial G 1 phase. In comparison to the initial CHT3 peak in the efg1 deletion, this peak is weaker in intensity and later in timing (not present at 0 or 10 min). We believe this initial peak of CHT3 in hgc1 and efg1 T179A cells reveals hypha-specific induction of Ace2 activity by Cbk1 and reveals that Ace2 activity is normally repressed by Cdc28-Hgc1 phosphorylation of Efg1 in wild-type cells during germ tube formation. In support of this, we have observed a strong Cbk1-GFP localization to the tips of emergent germ tubes minutes after their release into hyphal inducing conditions when they are still unbudded G 1 cells (our unpublished data). Ace2 target genes expressed in early G 1 include potential signaling molecules and cell cycle regulators in addition to enzymes involved in septum degradation and cell wall dynamics. Repression of these genes during germ tube formation may be critical for proper differentiation/morphogenesis. Regulatory events during the initial germ tube formation in G 1 cells could have a profound impact on proper development later on. As an example, phosphorylation of Cdc11 during the first few minutes of germ tube formation has shown to affect events an entire cell cycle later (41) .
Efg1 and Ace2 converge on the promoters of Ace2 target genes. This convergent regulation can integrate developmental signals from Efg1 with temporal and spatial constraints from Ace2. Three lines of evidence support this model. Efg1 is detected at the promoters of CHT3, SCW11, and DSE1. Second, Ace2 nuclear localization is not dramatically affected by deleting HGC1 or EFG1, nor is it dramatically different between yeast and hyphal cells. This suggests that Hgc1 and Efg1 do not function through altering either level or nuclear localization of Ace2. Finally, expression of CHT3 still remains cyclical and restricted to G 1 phase of the cell cycle in the absence of Efg1, indicating that the cell cycle regulation of Ace2 nuclear localization remains intact. The unique timing of the hypha-specific repression of CHT3 expression in G 1 during hyphal growth is intriguing. Ace2 is detected in the nucleus only during late M and early G 1 . However, classical Cdc28 cyclins are low during this period of the cell cycle. Hgc1 is an exception. It is expressed in all phases of the cell cycle during hyphal growth, including early G 1 . Therefore, phosphorylated Efg1 is expected to exist during all phases except when the phosphatase Cdc14 is high in late M. This timing fits perfectly with our observed timing of CHT3 repression.
The mechanisms of how phospho-Efg1 can repress the transcription of Ace2 target genes are not clear. Efg1 displays a preferential association with these promoters in hyphae and deletion of hgc1 causes a decreased level of Efg1 binding. Furthermore, Efg1
T179D binds stronger to these promoters than Efg1 during yeast phase. This suggests that the phosphorylation of Efg1 likely enhances its promoter association. This is consistent with the dominant nature of EFG1 T179D for cell chain formation in hgc1 cells during hyphal growth. What Efg1 does at Ace2 target gene promoters to repress these genes is unknown. One possible mechanism is that Efg1 directly or indirectly recruits chromatin remodeling factors, such as histone deacetylases, to repress transcription. Alternatively, it may prevent the binding of positive regulators of transcription, including even Ace2 itself. This possibility is supported by a recent finding in S. cerevisiae that Fkh2 at the promoters of many Swi5-target genes acts as an antiactivator by preventing Ace2 binding (51) . The second model is not supported by our data, since little difference in Ace2 binding at its promoters is observed between yeast and hyphal cells. However, the Ace2 ChIP signal is too low to be conclusive. Additional experiments are necessary to further differentiate/determine the potential mechanisms.
The role of APSES transcription factors in regulating cell chain formation during development may be conserved. Overproducing StuA in A. nidulans generates large conidiophores with long chains of reiterated metulae (8) . Overexpression of PHD1 in diploid S. cerevisiae displays enhanced pseudohyphal formation (15) . Both StuA and Phd1 share the conserved CDK phosphorylation site with Efg1 at T179. Interestingly, CLN1 is upregulated in pseudohyphae and Cdc28-Cln1 plays an essential role in pseudohyphal development in S. cerevisiae (31) . Phd1 is on the list of potential targets of CDK in a screen for Cdc28 phosphorylated proteins (49) . In examining previously published genome-wide expression data for genes modulated during pseudohyphal growth (38), we found that the levels of CTS1, SCW11, and PYR3 are lower in pseudohyphae. Close examination of three published genome-wide ChIP experiments in S. cerevisiae reveals that Phd1 is detected on the promoters of 9 of 18 Ace2 target genes ( Table 2 ). The conservation of Phd1 and Efg1 binding to Ace2 target genes is astonishing considering the estimated divergence of S. cerevisiae and C. albicans happened more than 300 million years ago (46) and the rapid turnover of transcription factor binding sites in evolution (6, 48) . 
